XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.460
-0.009 (-1.86%)
At close: Mar 9, 2026, 4:00 PM EDT
0.460
-0.000 (-0.02%)
After-hours: Mar 9, 2026, 4:10 PM EDT
XORTX Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
| Market Capitalization | 3 | 4 | 4 | 4 | 12 | 26 | |
| Market Cap Growth | -35.37% | -4.38% | -6.84% | -63.14% | -53.60% | 177.78% | |
| Enterprise Value | 2 | 3 | 2 | -1 | 3 | 22 | |
| Last Close Price | 0.47 | 0.56 | 1.13 | 2.31 | 7.27 | 18.45 | |
| PB Ratio | 1.47 | 1.88 | 1.23 | 0.95 | 1.70 | 1.94 | |
| P/TBV Ratio | 1.62 | 2.06 | 1.30 | 0.98 | 1.75 | 1.97 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.00 | 0.01 | - | |
| Net Debt / Equity Ratio | -0.40 | -0.40 | -0.73 | -0.74 | -1.48 | -1.13 | |
| Net Debt / EBITDA Ratio | 0.33 | 0.33 | 0.94 | 0.71 | 1.12 | 6.48 | |
| Net Debt / FCF Ratio | 0.30 | 0.30 | 0.66 | 0.52 | 1.26 | 3.10 | |
| Quick Ratio | 1.58 | 1.58 | 3.29 | 4.25 | 6.96 | 26.97 | |
| Current Ratio | 2.11 | 2.11 | 3.53 | 4.93 | 7.21 | 28.78 | |
| Return on Equity (ROE) | -98.00% | -98.00% | -83.06% | -37.08% | -76.43% | -22.25% | |
| Return on Assets (ROA) | -46.84% | -46.84% | -34.21% | -34.72% | -38.82% | -15.04% | |
| Return on Capital Employed (ROCE) | -121.80% | -121.80% | -78.40% | -106.80% | -85.10% | -13.70% | |
| Earnings Yield | -86.60% | -67.94% | -81.03% | -49.17% | -64.82% | -6.15% | |
| FCF Yield | -90.26% | -70.81% | -89.96% | -150.08% | -68.74% | -18.71% | |
| Buyback Yield / Dilution | -64.48% | -64.48% | -45.25% | -33.91% | -35.25% | -47.77% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.